Excision BioTherapeutics Appoints Veteran Genome Editing Expert TJ Cradick, PhD as Chief Scientific Officer  San Francisco, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Excision BioTherapeutics, a biotechnology company dedicated to curing viral infectious disease using CRISPR, today announced the appointment of TJ...

HIV Eliminated from the Genomes of Living Animals; Excision BioTherapeutics Advancing the Innovation to Clinical Development Philadelphia, July 02, 2019 (GLOBE NEWSWIRE) -- Researchers at the Lewis Katz School of Medicine at Temple University and the University of Nebraska Medical Center (UNMC) have for the first time in...

Global Mice Model Market worth 1,370.5 million USD by 2023 LONDON, July 23, 2018 (GLOBE NEWSWIRE) -- According to the latest publication from Meticulous Research®, the global mice model market is expected to reach USD 1,370.5 million by 2023, at a CAGR of...